A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia.
Litzow MR, Lee S, Bennett JM, Dewald GW, Gallagher RE, Jain V, Paietta EM, Racevskis J, Rousey SR, Mazza JJ, Tallman MS.
Haematologica. 2006 Aug;91(8):1105-8. Epub 2006 Jul 25.PMID: 16870552 [PubMed - indexed for MEDLINE]Related articlesFree article